nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B7—Epirubicin—thyroid cancer	0.191	0.268	CbGbCtD
Losartan—UGT1A1—Sorafenib—thyroid cancer	0.145	0.203	CbGbCtD
Losartan—ALB—Vandetanib—thyroid cancer	0.091	0.128	CbGbCtD
Losartan—CYP3A5—Sorafenib—thyroid cancer	0.0441	0.0618	CbGbCtD
Losartan—CYP2C8—Sorafenib—thyroid cancer	0.0424	0.0594	CbGbCtD
Losartan—CYP2C19—Sorafenib—thyroid cancer	0.0356	0.0498	CbGbCtD
Losartan—CYP1A2—Sorafenib—thyroid cancer	0.0328	0.046	CbGbCtD
Losartan—CYP2C9—Sorafenib—thyroid cancer	0.0296	0.0414	CbGbCtD
Losartan—ABCB1—Sorafenib—thyroid cancer	0.0287	0.0402	CbGbCtD
Losartan—CYP3A4—Vandetanib—thyroid cancer	0.0285	0.04	CbGbCtD
Losartan—ABCB1—Doxorubicin—thyroid cancer	0.0174	0.0244	CbGbCtD
Losartan—CYP3A4—Sorafenib—thyroid cancer	0.0172	0.0241	CbGbCtD
Losartan—CYP3A4—Doxorubicin—thyroid cancer	0.0104	0.0146	CbGbCtD
Losartan—Telmisartan—PPARG—thyroid cancer	0.00283	1	CrCbGaD
Losartan—Dermatitis—Vandetanib—thyroid cancer	0.000573	0.00269	CcSEcCtD
Losartan—Headache—Vandetanib—thyroid cancer	0.00057	0.00267	CcSEcCtD
Losartan—Pulmonary oedema—Epirubicin—thyroid cancer	0.000566	0.00265	CcSEcCtD
Losartan—Skin exfoliation—Doxorubicin—thyroid cancer	0.000561	0.00263	CcSEcCtD
Losartan—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000559	0.00262	CcSEcCtD
Losartan—Blood urea increased—Doxorubicin—thyroid cancer	0.000555	0.0026	CcSEcCtD
Losartan—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000552	0.00259	CcSEcCtD
Losartan—Dyspnoea—Sorafenib—thyroid cancer	0.000547	0.00256	CcSEcCtD
Losartan—Nausea—Vandetanib—thyroid cancer	0.00054	0.00253	CcSEcCtD
Losartan—Dyspepsia—Sorafenib—thyroid cancer	0.00054	0.00253	CcSEcCtD
Losartan—Decreased appetite—Sorafenib—thyroid cancer	0.000533	0.0025	CcSEcCtD
Losartan—Ecchymosis—Doxorubicin—thyroid cancer	0.000532	0.00249	CcSEcCtD
Losartan—Diabetes mellitus—Epirubicin—thyroid cancer	0.00053	0.00249	CcSEcCtD
Losartan—Fatigue—Sorafenib—thyroid cancer	0.000529	0.00248	CcSEcCtD
Losartan—Photosensitivity—Epirubicin—thyroid cancer	0.000525	0.00246	CcSEcCtD
Losartan—Pain—Sorafenib—thyroid cancer	0.000525	0.00246	CcSEcCtD
Losartan—Constipation—Sorafenib—thyroid cancer	0.000525	0.00246	CcSEcCtD
Losartan—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000523	0.00245	CcSEcCtD
Losartan—Vascular purpura—Epirubicin—thyroid cancer	0.000516	0.00242	CcSEcCtD
Losartan—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000502	0.00235	CcSEcCtD
Losartan—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000491	0.0023	CcSEcCtD
Losartan—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000489	0.00229	CcSEcCtD
Losartan—Urticaria—Sorafenib—thyroid cancer	0.000487	0.00228	CcSEcCtD
Losartan—Photosensitivity—Doxorubicin—thyroid cancer	0.000486	0.00228	CcSEcCtD
Losartan—Abdominal pain—Sorafenib—thyroid cancer	0.000485	0.00227	CcSEcCtD
Losartan—Body temperature increased—Sorafenib—thyroid cancer	0.000485	0.00227	CcSEcCtD
Losartan—Renal impairment—Epirubicin—thyroid cancer	0.000485	0.00227	CcSEcCtD
Losartan—Purpura—Epirubicin—thyroid cancer	0.000479	0.00224	CcSEcCtD
Losartan—Vascular purpura—Doxorubicin—thyroid cancer	0.000477	0.00224	CcSEcCtD
Losartan—Hypoglycaemia—Epirubicin—thyroid cancer	0.000473	0.00222	CcSEcCtD
Losartan—Hyponatraemia—Epirubicin—thyroid cancer	0.000463	0.00217	CcSEcCtD
Losartan—Pain in extremity—Epirubicin—thyroid cancer	0.000461	0.00216	CcSEcCtD
Losartan—Migraine—Epirubicin—thyroid cancer	0.000454	0.00213	CcSEcCtD
Losartan—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000452	0.00212	CcSEcCtD
Losartan—Hypersensitivity—Sorafenib—thyroid cancer	0.000452	0.00212	CcSEcCtD
Losartan—Renal impairment—Doxorubicin—thyroid cancer	0.000449	0.0021	CcSEcCtD
Losartan—Face oedema—Epirubicin—thyroid cancer	0.000445	0.00209	CcSEcCtD
Losartan—Purpura—Doxorubicin—thyroid cancer	0.000443	0.00208	CcSEcCtD
Losartan—Asthenia—Sorafenib—thyroid cancer	0.00044	0.00206	CcSEcCtD
Losartan—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000437	0.00205	CcSEcCtD
Losartan—Pruritus—Sorafenib—thyroid cancer	0.000434	0.00203	CcSEcCtD
Losartan—Ataxia—Epirubicin—thyroid cancer	0.000434	0.00203	CcSEcCtD
Losartan—Blood creatinine increased—Epirubicin—thyroid cancer	0.000432	0.00203	CcSEcCtD
Losartan—Hyponatraemia—Doxorubicin—thyroid cancer	0.000429	0.00201	CcSEcCtD
Losartan—Pain in extremity—Doxorubicin—thyroid cancer	0.000427	0.002	CcSEcCtD
Losartan—Dry skin—Epirubicin—thyroid cancer	0.000423	0.00198	CcSEcCtD
Losartan—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000421	0.00197	CcSEcCtD
Losartan—Migraine—Doxorubicin—thyroid cancer	0.00042	0.00197	CcSEcCtD
Losartan—Diarrhoea—Sorafenib—thyroid cancer	0.00042	0.00197	CcSEcCtD
Losartan—Breast disorder—Epirubicin—thyroid cancer	0.000417	0.00195	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000415	0.00195	CcSEcCtD
Losartan—Face oedema—Doxorubicin—thyroid cancer	0.000412	0.00193	CcSEcCtD
Losartan—Gastritis—Epirubicin—thyroid cancer	0.000408	0.00191	CcSEcCtD
Losartan—Muscular weakness—Epirubicin—thyroid cancer	0.000407	0.00191	CcSEcCtD
Losartan—Dizziness—Sorafenib—thyroid cancer	0.000406	0.0019	CcSEcCtD
Losartan—Ataxia—Doxorubicin—thyroid cancer	0.000401	0.00188	CcSEcCtD
Losartan—Blood creatinine increased—Doxorubicin—thyroid cancer	0.0004	0.00187	CcSEcCtD
Losartan—Influenza—Epirubicin—thyroid cancer	0.000399	0.00187	CcSEcCtD
Losartan—Eosinophilia—Epirubicin—thyroid cancer	0.000395	0.00185	CcSEcCtD
Losartan—Dry skin—Doxorubicin—thyroid cancer	0.000391	0.00183	CcSEcCtD
Losartan—Pancreatitis—Epirubicin—thyroid cancer	0.000391	0.00183	CcSEcCtD
Losartan—Vomiting—Sorafenib—thyroid cancer	0.00039	0.00183	CcSEcCtD
Losartan—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00039	0.00183	CcSEcCtD
Losartan—Angina pectoris—Epirubicin—thyroid cancer	0.000388	0.00182	CcSEcCtD
Losartan—Rash—Sorafenib—thyroid cancer	0.000387	0.00181	CcSEcCtD
Losartan—Dermatitis—Sorafenib—thyroid cancer	0.000386	0.00181	CcSEcCtD
Losartan—Breast disorder—Doxorubicin—thyroid cancer	0.000386	0.00181	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000384	0.0018	CcSEcCtD
Losartan—Headache—Sorafenib—thyroid cancer	0.000384	0.0018	CcSEcCtD
Losartan—Bronchitis—Epirubicin—thyroid cancer	0.000383	0.0018	CcSEcCtD
Losartan—Gastritis—Doxorubicin—thyroid cancer	0.000378	0.00177	CcSEcCtD
Losartan—Muscular weakness—Doxorubicin—thyroid cancer	0.000376	0.00176	CcSEcCtD
Losartan—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000371	0.00174	CcSEcCtD
Losartan—Influenza—Doxorubicin—thyroid cancer	0.000369	0.00173	CcSEcCtD
Losartan—Pollakiuria—Epirubicin—thyroid cancer	0.000368	0.00173	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—thyroid cancer	0.000365	0.00171	CcSEcCtD
Losartan—Nausea—Sorafenib—thyroid cancer	0.000364	0.00171	CcSEcCtD
Losartan—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000364	0.00171	CcSEcCtD
Losartan—Weight increased—Epirubicin—thyroid cancer	0.000363	0.0017	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—thyroid cancer	0.000362	0.0017	CcSEcCtD
Losartan—Hyperglycaemia—Epirubicin—thyroid cancer	0.00036	0.00169	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—thyroid cancer	0.000359	0.00168	CcSEcCtD
Losartan—Pneumonia—Epirubicin—thyroid cancer	0.000358	0.00168	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—thyroid cancer	0.000355	0.00166	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000352	0.00165	CcSEcCtD
Losartan—Renal failure—Epirubicin—thyroid cancer	0.000349	0.00164	CcSEcCtD
Losartan—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000348	0.00163	CcSEcCtD
Losartan—Jaundice—Epirubicin—thyroid cancer	0.000347	0.00162	CcSEcCtD
Losartan—Urinary tract infection—Epirubicin—thyroid cancer	0.000346	0.00162	CcSEcCtD
Losartan—Conjunctivitis—Epirubicin—thyroid cancer	0.000346	0.00162	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000343	0.00161	CcSEcCtD
Losartan—Sweating—Epirubicin—thyroid cancer	0.000341	0.0016	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—thyroid cancer	0.000341	0.0016	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000337	0.00158	CcSEcCtD
Losartan—Weight increased—Doxorubicin—thyroid cancer	0.000336	0.00157	CcSEcCtD
Losartan—Epistaxis—Epirubicin—thyroid cancer	0.000335	0.00157	CcSEcCtD
Losartan—Sinusitis—Epirubicin—thyroid cancer	0.000334	0.00156	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000333	0.00156	CcSEcCtD
Losartan—Agranulocytosis—Epirubicin—thyroid cancer	0.000332	0.00155	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—thyroid cancer	0.000331	0.00155	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000326	0.00153	CcSEcCtD
Losartan—Renal failure—Doxorubicin—thyroid cancer	0.000323	0.00152	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000322	0.00151	CcSEcCtD
Losartan—Jaundice—Doxorubicin—thyroid cancer	0.000321	0.0015	CcSEcCtD
Losartan—Rhinitis—Epirubicin—thyroid cancer	0.00032	0.0015	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—thyroid cancer	0.00032	0.0015	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—thyroid cancer	0.00032	0.0015	CcSEcCtD
Losartan—Hepatitis—Epirubicin—thyroid cancer	0.000319	0.0015	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—thyroid cancer	0.000318	0.00149	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—thyroid cancer	0.000317	0.00148	CcSEcCtD
Losartan—Sweating—Doxorubicin—thyroid cancer	0.000315	0.00148	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—thyroid cancer	0.00031	0.00145	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—thyroid cancer	0.000309	0.00145	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—thyroid cancer	0.000307	0.00144	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—thyroid cancer	0.000302	0.00141	CcSEcCtD
Losartan—Tinnitus—Epirubicin—thyroid cancer	0.000298	0.00139	CcSEcCtD
Losartan—Flushing—Epirubicin—thyroid cancer	0.000296	0.00139	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—thyroid cancer	0.000296	0.00139	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—thyroid cancer	0.000295	0.00138	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000294	0.00138	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—thyroid cancer	0.000293	0.00137	CcSEcCtD
Losartan—Angiopathy—Epirubicin—thyroid cancer	0.00029	0.00136	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—thyroid cancer	0.000285	0.00134	CcSEcCtD
Losartan—Alopecia—Epirubicin—thyroid cancer	0.000282	0.00132	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—thyroid cancer	0.000279	0.00131	CcSEcCtD
Losartan—Erythema—Epirubicin—thyroid cancer	0.000278	0.0013	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—thyroid cancer	0.000275	0.00129	CcSEcCtD
Losartan—Flushing—Doxorubicin—thyroid cancer	0.000274	0.00128	CcSEcCtD
Losartan—Flatulence—Epirubicin—thyroid cancer	0.000274	0.00128	CcSEcCtD
Losartan—Tension—Epirubicin—thyroid cancer	0.000273	0.00128	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—thyroid cancer	0.000272	0.00128	CcSEcCtD
Losartan—Nervousness—Epirubicin—thyroid cancer	0.00027	0.00126	CcSEcCtD
Losartan—Back pain—Epirubicin—thyroid cancer	0.000269	0.00126	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—thyroid cancer	0.000268	0.00126	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—thyroid cancer	0.000267	0.00125	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—thyroid cancer	0.000264	0.00124	CcSEcCtD
Losartan—Vision blurred—Epirubicin—thyroid cancer	0.000262	0.00123	CcSEcCtD
Losartan—Alopecia—Doxorubicin—thyroid cancer	0.000261	0.00122	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—thyroid cancer	0.000258	0.00121	CcSEcCtD
Losartan—Erythema—Doxorubicin—thyroid cancer	0.000257	0.0012	CcSEcCtD
Losartan—Anaemia—Epirubicin—thyroid cancer	0.000257	0.0012	CcSEcCtD
Losartan—Agitation—Epirubicin—thyroid cancer	0.000255	0.0012	CcSEcCtD
Losartan—Flatulence—Doxorubicin—thyroid cancer	0.000253	0.00119	CcSEcCtD
Losartan—Tension—Doxorubicin—thyroid cancer	0.000252	0.00118	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—thyroid cancer	0.000252	0.00118	CcSEcCtD
Losartan—Malaise—Epirubicin—thyroid cancer	0.000251	0.00117	CcSEcCtD
Losartan—Nervousness—Doxorubicin—thyroid cancer	0.00025	0.00117	CcSEcCtD
Losartan—Vertigo—Epirubicin—thyroid cancer	0.00025	0.00117	CcSEcCtD
Losartan—Syncope—Epirubicin—thyroid cancer	0.000249	0.00117	CcSEcCtD
Losartan—Leukopenia—Epirubicin—thyroid cancer	0.000249	0.00117	CcSEcCtD
Losartan—Back pain—Doxorubicin—thyroid cancer	0.000249	0.00117	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—thyroid cancer	0.000247	0.00116	CcSEcCtD
Losartan—Palpitations—Epirubicin—thyroid cancer	0.000246	0.00115	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—thyroid cancer	0.000244	0.00114	CcSEcCtD
Losartan—Cough—Epirubicin—thyroid cancer	0.000242	0.00114	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—thyroid cancer	0.000242	0.00114	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000239	0.00112	CcSEcCtD
Losartan—Anaemia—Doxorubicin—thyroid cancer	0.000238	0.00111	CcSEcCtD
Losartan—Arthralgia—Epirubicin—thyroid cancer	0.000237	0.00111	CcSEcCtD
Losartan—Myalgia—Epirubicin—thyroid cancer	0.000237	0.00111	CcSEcCtD
Losartan—Chest pain—Epirubicin—thyroid cancer	0.000237	0.00111	CcSEcCtD
Losartan—Agitation—Doxorubicin—thyroid cancer	0.000236	0.00111	CcSEcCtD
Losartan—Anxiety—Epirubicin—thyroid cancer	0.000236	0.0011	CcSEcCtD
Losartan—Discomfort—Epirubicin—thyroid cancer	0.000234	0.0011	CcSEcCtD
Losartan—Malaise—Doxorubicin—thyroid cancer	0.000232	0.00109	CcSEcCtD
Losartan—Dry mouth—Epirubicin—thyroid cancer	0.000231	0.00108	CcSEcCtD
Losartan—Vertigo—Doxorubicin—thyroid cancer	0.000231	0.00108	CcSEcCtD
Losartan—Syncope—Doxorubicin—thyroid cancer	0.000231	0.00108	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—thyroid cancer	0.00023	0.00108	CcSEcCtD
Losartan—Confusional state—Epirubicin—thyroid cancer	0.000229	0.00107	CcSEcCtD
Losartan—Palpitations—Doxorubicin—thyroid cancer	0.000227	0.00106	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—thyroid cancer	0.000227	0.00106	CcSEcCtD
Losartan—Oedema—Epirubicin—thyroid cancer	0.000227	0.00106	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—thyroid cancer	0.000226	0.00106	CcSEcCtD
Losartan—Infection—Epirubicin—thyroid cancer	0.000225	0.00106	CcSEcCtD
Losartan—Cough—Doxorubicin—thyroid cancer	0.000224	0.00105	CcSEcCtD
Losartan—Shock—Epirubicin—thyroid cancer	0.000223	0.00105	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—thyroid cancer	0.000222	0.00104	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—thyroid cancer	0.000222	0.00104	CcSEcCtD
Losartan—Tachycardia—Epirubicin—thyroid cancer	0.000221	0.00104	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—thyroid cancer	0.000219	0.00103	CcSEcCtD
Losartan—Chest pain—Doxorubicin—thyroid cancer	0.000219	0.00103	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—thyroid cancer	0.000219	0.00103	CcSEcCtD
Losartan—Myalgia—Doxorubicin—thyroid cancer	0.000219	0.00103	CcSEcCtD
Losartan—Anxiety—Doxorubicin—thyroid cancer	0.000218	0.00102	CcSEcCtD
Losartan—Discomfort—Doxorubicin—thyroid cancer	0.000216	0.00101	CcSEcCtD
Losartan—Anorexia—Epirubicin—thyroid cancer	0.000216	0.00101	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—thyroid cancer	0.000214	0.001	CcSEcCtD
Losartan—Hypotension—Epirubicin—thyroid cancer	0.000212	0.000993	CcSEcCtD
Losartan—Confusional state—Doxorubicin—thyroid cancer	0.000212	0.000991	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00021	0.000983	CcSEcCtD
Losartan—Oedema—Doxorubicin—thyroid cancer	0.00021	0.000983	CcSEcCtD
Losartan—Infection—Doxorubicin—thyroid cancer	0.000208	0.000977	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000207	0.000968	CcSEcCtD
Losartan—Shock—Doxorubicin—thyroid cancer	0.000206	0.000967	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—thyroid cancer	0.000206	0.000964	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000205	0.000963	CcSEcCtD
Losartan—Insomnia—Epirubicin—thyroid cancer	0.000205	0.000961	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—thyroid cancer	0.000205	0.00096	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—thyroid cancer	0.000204	0.000954	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000203	0.000951	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—thyroid cancer	0.000202	0.000947	CcSEcCtD
Losartan—Somnolence—Epirubicin—thyroid cancer	0.000202	0.000945	CcSEcCtD
Losartan—Anorexia—Doxorubicin—thyroid cancer	0.0002	0.000937	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—thyroid cancer	0.0002	0.000935	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—thyroid cancer	0.000197	0.000924	CcSEcCtD
Losartan—Hypotension—Doxorubicin—thyroid cancer	0.000196	0.000919	CcSEcCtD
Losartan—Fatigue—Epirubicin—thyroid cancer	0.000195	0.000916	CcSEcCtD
Losartan—Constipation—Epirubicin—thyroid cancer	0.000194	0.000909	CcSEcCtD
Losartan—Pain—Epirubicin—thyroid cancer	0.000194	0.000909	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000191	0.000896	CcSEcCtD
Losartan—Insomnia—Doxorubicin—thyroid cancer	0.00019	0.000889	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—thyroid cancer	0.000188	0.000883	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—thyroid cancer	0.000187	0.000877	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—thyroid cancer	0.000187	0.000876	CcSEcCtD
Losartan—Somnolence—Doxorubicin—thyroid cancer	0.000187	0.000874	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000185	0.000869	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—thyroid cancer	0.000185	0.000866	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—thyroid cancer	0.000182	0.000855	CcSEcCtD
Losartan—Fatigue—Doxorubicin—thyroid cancer	0.000181	0.000848	CcSEcCtD
Losartan—Urticaria—Epirubicin—thyroid cancer	0.00018	0.000844	CcSEcCtD
Losartan—Pain—Doxorubicin—thyroid cancer	0.000179	0.000841	CcSEcCtD
Losartan—Constipation—Doxorubicin—thyroid cancer	0.000179	0.000841	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—thyroid cancer	0.000179	0.00084	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—thyroid cancer	0.000179	0.00084	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—thyroid cancer	0.000173	0.00081	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000172	0.000804	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—thyroid cancer	0.000167	0.000783	CcSEcCtD
Losartan—Urticaria—Doxorubicin—thyroid cancer	0.000167	0.000781	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—thyroid cancer	0.000166	0.000777	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—thyroid cancer	0.000166	0.000777	CcSEcCtD
Losartan—Asthenia—Epirubicin—thyroid cancer	0.000163	0.000762	CcSEcCtD
Losartan—Pruritus—Epirubicin—thyroid cancer	0.00016	0.000752	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—thyroid cancer	0.000155	0.000727	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—thyroid cancer	0.000155	0.000724	CcSEcCtD
Losartan—Asthenia—Doxorubicin—thyroid cancer	0.000151	0.000705	CcSEcCtD
Losartan—Dizziness—Epirubicin—thyroid cancer	0.00015	0.000703	CcSEcCtD
Losartan—Pruritus—Doxorubicin—thyroid cancer	0.000148	0.000696	CcSEcCtD
Losartan—Vomiting—Epirubicin—thyroid cancer	0.000144	0.000676	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—thyroid cancer	0.000144	0.000673	CcSEcCtD
Losartan—Rash—Epirubicin—thyroid cancer	0.000143	0.00067	CcSEcCtD
Losartan—Dermatitis—Epirubicin—thyroid cancer	0.000143	0.000669	CcSEcCtD
Losartan—Headache—Epirubicin—thyroid cancer	0.000142	0.000666	CcSEcCtD
Losartan—Dizziness—Doxorubicin—thyroid cancer	0.000139	0.00065	CcSEcCtD
Losartan—Nausea—Epirubicin—thyroid cancer	0.000135	0.000631	CcSEcCtD
Losartan—Vomiting—Doxorubicin—thyroid cancer	0.000133	0.000625	CcSEcCtD
Losartan—Rash—Doxorubicin—thyroid cancer	0.000132	0.00062	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—thyroid cancer	0.000132	0.000619	CcSEcCtD
Losartan—Headache—Doxorubicin—thyroid cancer	0.000131	0.000616	CcSEcCtD
Losartan—Nausea—Doxorubicin—thyroid cancer	0.000125	0.000584	CcSEcCtD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.14e-05	0.0013	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.13e-05	0.0013	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	9.11e-05	0.00129	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—SST—thyroid cancer	8.99e-05	0.00128	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PTCH1—thyroid cancer	8.92e-05	0.00127	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	8.81e-05	0.00125	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PTGS2—thyroid cancer	8.72e-05	0.00124	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.72e-05	0.00124	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.69e-05	0.00123	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CALCA—thyroid cancer	8.65e-05	0.00123	CbGpPWpGaD
Losartan—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.53e-05	0.00121	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TCF7L1—thyroid cancer	8.47e-05	0.0012	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—HPGD—thyroid cancer	8.26e-05	0.00117	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—RXRA—thyroid cancer	8.2e-05	0.00116	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—SST—thyroid cancer	8.16e-05	0.00116	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.95e-05	0.00113	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CALCA—thyroid cancer	7.86e-05	0.00112	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	7.81e-05	0.00111	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MINPP1—thyroid cancer	7.79e-05	0.00111	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	7.75e-05	0.0011	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.64e-05	0.00108	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PTEN—thyroid cancer	7.6e-05	0.00108	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	7.59e-05	0.00108	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—HPGD—thyroid cancer	7.57e-05	0.00107	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—RXRA—thyroid cancer	7.48e-05	0.00106	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	7.36e-05	0.00105	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CDK1—thyroid cancer	7.11e-05	0.00101	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	7.09e-05	0.00101	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.95e-05	0.000987	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—TPR—thyroid cancer	6.86e-05	0.000975	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.79e-05	0.000965	CbGpPWpGaD
Losartan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	6.79e-05	0.000964	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PRKAR1A—thyroid cancer	6.75e-05	0.000959	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MINPP1—thyroid cancer	6.75e-05	0.000958	CbGpPWpGaD
Losartan—ALB—Metabolism—MINPP1—thyroid cancer	6.71e-05	0.000953	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NDUFA13—thyroid cancer	6.62e-05	0.000941	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—TPR—thyroid cancer	6.47e-05	0.000919	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	6.45e-05	0.000916	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.42e-05	0.000911	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—RXRA—thyroid cancer	6.39e-05	0.000907	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	6.36e-05	0.000904	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CHST14—thyroid cancer	6.23e-05	0.000885	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TSHR—thyroid cancer	6.2e-05	0.000881	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.14e-05	0.000872	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	6.1e-05	0.000867	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PRKAR1A—thyroid cancer	6.1e-05	0.000866	CbGpPWpGaD
Losartan—ALB—Hemostasis—PRKAR1A—thyroid cancer	6.03e-05	0.000856	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MINPP1—thyroid cancer	6.02e-05	0.000856	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MINPP1—thyroid cancer	5.88e-05	0.000835	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—TPR—thyroid cancer	5.84e-05	0.000829	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.84e-05	0.000829	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MEN1—thyroid cancer	5.83e-05	0.000828	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TP53—thyroid cancer	5.81e-05	0.000825	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.77e-05	0.000819	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	5.74e-05	0.000816	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NDUFA13—thyroid cancer	5.74e-05	0.000815	CbGpPWpGaD
Losartan—ALB—Metabolism—NDUFA13—thyroid cancer	5.71e-05	0.00081	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MINPP1—thyroid cancer	5.49e-05	0.00078	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CHST14—thyroid cancer	5.39e-05	0.000766	CbGpPWpGaD
Losartan—ALB—Metabolism—CHST14—thyroid cancer	5.36e-05	0.000762	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	5.3e-05	0.000753	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	5.3e-05	0.000753	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTCH1—thyroid cancer	5.27e-05	0.000749	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.22e-05	0.000741	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	5.19e-05	0.000737	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SLC5A5—thyroid cancer	5.14e-05	0.00073	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NDUFA13—thyroid cancer	5.12e-05	0.000727	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—HPGD—thyroid cancer	5.02e-05	0.000713	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NDUFA13—thyroid cancer	5e-05	0.00071	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.93e-05	0.0007	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	4.84e-05	0.000688	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SST—thyroid cancer	4.82e-05	0.000685	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CHST14—thyroid cancer	4.82e-05	0.000684	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—TPR—thyroid cancer	4.74e-05	0.000674	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CHST14—thyroid cancer	4.7e-05	0.000668	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MINPP1—thyroid cancer	4.69e-05	0.000667	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NDUFA13—thyroid cancer	4.67e-05	0.000663	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	4.67e-05	0.000663	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	4.65e-05	0.00066	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	4.65e-05	0.00066	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CALCA—thyroid cancer	4.64e-05	0.000659	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.57e-05	0.000649	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.54e-05	0.000645	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CHST14—thyroid cancer	4.39e-05	0.000624	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—AKT1—thyroid cancer	4.38e-05	0.000622	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SLC5A5—thyroid cancer	4.37e-05	0.000621	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HPGD—thyroid cancer	4.35e-05	0.000618	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TPR—thyroid cancer	4.35e-05	0.000617	CbGpPWpGaD
Losartan—ALB—Metabolism—HPGD—thyroid cancer	4.32e-05	0.000614	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—RXRA—thyroid cancer	4.32e-05	0.000613	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.3e-05	0.000611	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	4.28e-05	0.000607	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDK1—thyroid cancer	4.2e-05	0.000597	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—RXRA—thyroid cancer	4.07e-05	0.000578	CbGpPWpGaD
Losartan—ALB—Hemostasis—IFNA2—thyroid cancer	3.99e-05	0.000567	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.99e-05	0.000567	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.97e-05	0.000564	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.96e-05	0.000562	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HPGD—thyroid cancer	3.88e-05	0.000551	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.88e-05	0.00055	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HPGD—thyroid cancer	3.79e-05	0.000538	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CHST14—thyroid cancer	3.75e-05	0.000533	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—RXRA—thyroid cancer	3.67e-05	0.000521	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.66e-05	0.000519	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.62e-05	0.000514	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SLC5A5—thyroid cancer	3.55e-05	0.000504	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HPGD—thyroid cancer	3.54e-05	0.000503	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.53e-05	0.000501	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.51e-05	0.000498	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.48e-05	0.000494	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRG1—thyroid cancer	3.37e-05	0.000479	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.33e-05	0.000474	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.3e-05	0.000469	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	3.25e-05	0.000462	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.19e-05	0.000453	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.15e-05	0.000447	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.08e-05	0.000437	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.05e-05	0.000433	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TERT—thyroid cancer	3.03e-05	0.00043	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HPGD—thyroid cancer	3.02e-05	0.00043	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—RXRA—thyroid cancer	2.98e-05	0.000424	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.92e-05	0.000415	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CHST14—thyroid cancer	2.9e-05	0.000411	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HIF1A—thyroid cancer	2.9e-05	0.000411	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TPR—thyroid cancer	2.88e-05	0.00041	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.87e-05	0.000408	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.84e-05	0.000403	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.73e-05	0.000388	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PPARG—thyroid cancer	2.73e-05	0.000387	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.66e-05	0.000378	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PPARG—thyroid cancer	2.57e-05	0.000365	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—NRAS—thyroid cancer	2.55e-05	0.000362	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TPR—thyroid cancer	2.5e-05	0.000355	CbGpPWpGaD
Losartan—ALB—Metabolism—TPR—thyroid cancer	2.48e-05	0.000353	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.46e-05	0.000349	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.45e-05	0.000348	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.45e-05	0.000348	CbGpPWpGaD
Losartan—ALB—Metabolism—PRKAR1A—thyroid cancer	2.44e-05	0.000347	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—BRAF—thyroid cancer	2.4e-05	0.000341	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HPGD—thyroid cancer	2.33e-05	0.000332	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PPARG—thyroid cancer	2.32e-05	0.000329	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TPR—thyroid cancer	2.23e-05	0.000317	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.23e-05	0.000316	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.21e-05	0.000315	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—KRAS—thyroid cancer	2.2e-05	0.000312	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.19e-05	0.000312	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TPR—thyroid cancer	2.18e-05	0.000309	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.18e-05	0.000309	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.16e-05	0.000307	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—thyroid cancer	2.14e-05	0.000305	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.14e-05	0.000304	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TPR—thyroid cancer	2.03e-05	0.000289	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—thyroid cancer	2.02e-05	0.000287	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2e-05	0.000284	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.99e-05	0.000282	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARG—thyroid cancer	1.88e-05	0.000268	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTEN—thyroid cancer	1.87e-05	0.000266	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.87e-05	0.000266	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—thyroid cancer	1.87e-05	0.000265	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.87e-05	0.000265	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC5A5—thyroid cancer	1.86e-05	0.000264	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.84e-05	0.000261	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—thyroid cancer	1.82e-05	0.000259	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—thyroid cancer	1.81e-05	0.000258	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—RXRA—thyroid cancer	1.81e-05	0.000258	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.81e-05	0.000257	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.76e-05	0.00025	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.75e-05	0.000249	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—thyroid cancer	1.75e-05	0.000249	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.74e-05	0.000247	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TPR—thyroid cancer	1.74e-05	0.000247	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.73e-05	0.000245	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.71e-05	0.000243	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTEN—thyroid cancer	1.69e-05	0.00024	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.67e-05	0.000237	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—thyroid cancer	1.65e-05	0.000234	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.63e-05	0.000231	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTEN—thyroid cancer	1.59e-05	0.000226	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—RXRA—thyroid cancer	1.57e-05	0.000223	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.56e-05	0.000222	CbGpPWpGaD
Losartan—ALB—Metabolism—RXRA—thyroid cancer	1.56e-05	0.000222	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.55e-05	0.00022	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.53e-05	0.000217	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.52e-05	0.000216	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.52e-05	0.000216	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—thyroid cancer	1.51e-05	0.000214	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—thyroid cancer	1.49e-05	0.000211	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.48e-05	0.00021	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.43e-05	0.000203	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—RXRA—thyroid cancer	1.4e-05	0.000199	CbGpPWpGaD
Losartan—ABCB1—Metabolism—RXRA—thyroid cancer	1.37e-05	0.000194	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.36e-05	0.000194	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.36e-05	0.000193	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TPR—thyroid cancer	1.34e-05	0.00019	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.32e-05	0.000187	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.3e-05	0.000185	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—thyroid cancer	1.3e-05	0.000184	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—thyroid cancer	1.29e-05	0.000184	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—thyroid cancer	1.28e-05	0.000182	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—RXRA—thyroid cancer	1.28e-05	0.000182	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.24e-05	0.000177	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.22e-05	0.000173	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.18e-05	0.000168	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—thyroid cancer	1.15e-05	0.000164	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—thyroid cancer	1.15e-05	0.000163	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—thyroid cancer	1.14e-05	0.000162	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—thyroid cancer	1.1e-05	0.000157	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RXRA—thyroid cancer	1.09e-05	0.000155	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—thyroid cancer	1.09e-05	0.000155	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—thyroid cancer	1.08e-05	0.000153	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.06e-05	0.000151	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—thyroid cancer	1.02e-05	0.000144	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1e-05	0.000143	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—thyroid cancer	9.92e-06	0.000141	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—thyroid cancer	9.86e-06	0.00014	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—thyroid cancer	9.73e-06	0.000138	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—thyroid cancer	9.62e-06	0.000137	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—thyroid cancer	9.16e-06	0.00013	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—thyroid cancer	9.01e-06	0.000128	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—thyroid cancer	8.85e-06	0.000126	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—thyroid cancer	8.64e-06	0.000123	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RXRA—thyroid cancer	8.43e-06	0.00012	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—thyroid cancer	8.07e-06	0.000115	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—thyroid cancer	7.86e-06	0.000112	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—thyroid cancer	7.8e-06	0.000111	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—thyroid cancer	7.76e-06	0.00011	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—thyroid cancer	7.45e-06	0.000106	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—thyroid cancer	6.96e-06	9.89e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—thyroid cancer	6.9e-06	9.8e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—thyroid cancer	6.82e-06	9.69e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—thyroid cancer	6.8e-06	9.66e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—thyroid cancer	6.8e-06	9.65e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—thyroid cancer	6.77e-06	9.61e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—thyroid cancer	6.35e-06	9.02e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—thyroid cancer	6.07e-06	8.63e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—thyroid cancer	5.93e-06	8.42e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—thyroid cancer	5.54e-06	7.87e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.43e-06	7.71e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—thyroid cancer	5.32e-06	7.56e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—thyroid cancer	4.73e-06	6.72e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—thyroid cancer	4.53e-06	6.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.19e-06	5.95e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—thyroid cancer	3.92e-06	5.57e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—thyroid cancer	3.9e-06	5.54e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—thyroid cancer	3.65e-06	5.19e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—thyroid cancer	3.5e-06	4.97e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—thyroid cancer	3.42e-06	4.85e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—thyroid cancer	3.19e-06	4.53e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—thyroid cancer	2.73e-06	3.87e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—thyroid cancer	2.1e-06	2.99e-05	CbGpPWpGaD
